Ascendis Health Limited

Johannesburg Stock Exchange ASC.JO

Ascendis Health Limited Price to Earnings Ratio (P/E) on January 14, 2025: 12.77

Ascendis Health Limited Price to Earnings Ratio (P/E) is 12.77 on January 14, 2025, a 93.70% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Ascendis Health Limited 52-week high Price to Earnings Ratio (P/E) is 246.38 on December 20, 2024, which is 1,829.84% above the current Price to Earnings Ratio (P/E).
  • Ascendis Health Limited 52-week low Price to Earnings Ratio (P/E) is 6.31 on February 28, 2024, which is -50.56% below the current Price to Earnings Ratio (P/E).
  • Ascendis Health Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 10.20.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
Johannesburg Stock Exchange: ASC.JO

Ascendis Health Limited

CEO Mr. A. Carl Neethling
IPO Date Nov. 22, 2013
Location South Africa
Headquarters 31 Georgian Crescent East
Employees 3,200
Sector Health Care
Industries
Description

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical segments. It offers body and skin products; and natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce brand names. The company also provides medical devices, and diagnostic laboratory equipment and consumables for operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, research and science institutes, etc.; generic pharmaceutical products, antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives; and products for the nervous system, cardiovascular system, dermatological products, and antimalarials, as well as other therapeutic products under the Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group brands. In addition, it exports its products. The company serves pharmacies, retailers, beauticians, and doctors. Ascendis Health Limited was incorporated in 2008 and is based in Johannesburg, South Africa.

Similar companies

AEG.JO

Aveng Limited

USD 0.67

0.47%

SOL.JO

Sasol Limited

USD 5.03

-1.74%

StockViz Staff

January 15, 2025

Any question? Send us an email